Results 21 to 30 of about 13,776 (222)

Androgenetic alopecia: a review [PDF]

open access: yes, 2017
Purpose Androgenetic alopecia, commonly known as male pattern baldness, is the most common type of progressive hair loss disorder in men. The aim of this paper is to review recent advances in understanding the pathophysiology and molecular mechanism
Caro, Gemma   +7 more
core   +1 more source

Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia

open access: yesDermatology and Therapy, 2023
Introduction This study assessed the levels of compliance to topical minoxidil (TM) among male and female patients with androgenetic alopecia (AGA) and analyzed the factors associated with minoxidil discontinuation.
Zari Shadi
doaj   +1 more source

Characterization of Soluplus/ASC-DP Nanoparticles Encapsulated with Minoxidil for Skin Targeting

open access: yesChemEngineering, 2021
Soluplus (Sol) is an amphiphilic graft copolymer capable of forming self-assembled micelles and L-ascorbyl 2,6-dipalmitate (ASC-DP) aggregates spontaneously to form micelles.
Rina Takayama   +4 more
doaj   +1 more source

Multi-therapies in androgenetic alopecia: review and clinical experiences. [PDF]

open access: yes, 2016
Androgenetic alopecia (AGA) is a genetically determined progressive hair-loss condition which represents the most common cause of hair loss in men. The use of the medical term androgenetic alopecia reflects current knowledge about the important role of
Anzalone, Alessia   +6 more
core   +1 more source

Nanopartículas Poliméricas en Dermocosmética [PDF]

open access: yes, 2015
Indexación: Web of Science; Scielo.Recent advances in the fields of biomaterials and nanotechnology have allowed the development of advanced nanoparticles for biomedical applications. Despite a vast number of nanostructures such as liposomes, solid­lipid
Bahamonde-Norambuena, D.   +5 more
core   +1 more source

Prolonged hypotension induced by ingesting a topical minoxidil solution: analysis of minoxidil and its metabolites

open access: yesAcute Medicine & Surgery, 2016
Case A 47‐year‐old man ingested 60 mL of a topical solution (3,000 mg minoxidil) and presented with prolonged hypotension. Treatment with dopamine hydrochloride and noradrenaline provided blood pressure control.
Satoshi Kikuchi   +4 more
doaj   +1 more source

Effect of High-Dose Topical Minoxidil on Erythrocyte Quality in SKH1 Hairless Mice

open access: yesAnimals, 2020
SKH1 hairless mice are widely used in carcinogenesis and dermatology research due to their bare skin, as exposure to different agents is facilitated. Minoxidil is a cosmetic drug that is recognized as a mitogenic agent, and mitogens are suggested to have
Eduardo Naranjo-Vázquez   +6 more
doaj   +1 more source

New Target for Minoxidil in the Treatment of Androgenetic Alopecia

open access: yesDrug Design, Development and Therapy, 2023
Yuqing Shen,1 Yuqi Zhu,1 Li Zhang,1 Jiayi Sun,1 Bo Xie,2 Hongyan Zhang,2 Xiuzu Song2 1Department of Dermatology, Hangzhou Third People’s Hospital, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Dermatology ...
Shen Y   +6 more
doaj  

Infantile generalized hypertrichosis caused by topical minoxidil [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2016
Rare cases of hypertrichosis have been associated with topically applied minoxidil. We present the first reported case in the Brazilian literature of generalized hypertrichosis affecting a 5-year-old child, following use of minoxidil 5%, 20 drops a day ...
Greice Rampon   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy